Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New acellular pertussis-containing paediatric combined vaccines.
Pines E, Barrand M, Fabre P, Salomon H, Blondeau C, Wood SC, Hoffenbach A. Pines E, et al. Among authors: salomon h. Vaccine. 1999 Mar 26;17(13-14):1650-6. doi: 10.1016/s0264-410x(98)00422-8. Vaccine. 1999. PMID: 10194818 Review.
Randomised study of the possible adjuvant effect of BCG vaccine on the immunogenicity of diphtheria-tetanus-acellular pertussis vaccine in Senegalese infants.
Simondon F, Preziosi MP, Pinchinat S, Yam A, Chabirand L, Wassilak S, Pines E, Trape JF, Salomon H, Hoffenbach A. Simondon F, et al. Among authors: salomon h. Eur J Clin Microbiol Infect Dis. 1999 Jan;18(1):23-9. doi: 10.1007/s100960050221. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10192710 Clinical Trial.
Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants.
Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schödel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, Hoffenbach A; Hexavalent Vaccine Trial Study Group. Mallet E, et al. Among authors: salomon h. Pediatr Infect Dis J. 2000 Dec;19(12):1119-27. doi: 10.1097/00006454-200012000-00001. Pediatr Infect Dis J. 2000. PMID: 11144370 Clinical Trial.
A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts >/=350/mm3.
Losso MH, Belloso WH, Emery S, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Nelson E, Law MG, Davey RT, Allende MC, Lane HC. Losso MH, et al. Among authors: salomon h. J Infect Dis. 2000 May;181(5):1614-21. doi: 10.1086/315430. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823761 Clinical Trial.
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Mocroft A, et al. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar. PLoS Med. 2015. PMID: 25826420 Free PMC article.
Interleukin-2 therapy in patients with HIV infection.
INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee; Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. INSIGHT-ESPRIT Study Group, et al. N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175. N Engl J Med. 2009. PMID: 19828532 Free PMC article. Clinical Trial.
209 results